Target Name: MIR3940
NCBI ID: G100500888
Other Name(s): hsa-mir-3940 | hsa-miR-3940-3p | hsa-miR-3940-5p | MicroRNA 3940 | mir-3940 | microRNA 3940

MIR3940: A Potential Drug Target and Biomarker

MIR3940 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a highly conserved gene that is expressed in various tissues and organs, including the brain, heart, and pancreas. MIR3940 is known for its role in cell signaling, specifically in the regulation of cell adhesion and migration.

The discovery of MIR3940 as a potential drug target comes from a team of researchers at the University of California, San Diego. The researchers identified MIR3940 as a potential drug target using a technique called RNA-based assays. They found that MIR3940 was highly expressed in various tissues and that it was involved in the regulation of cell adhesion and migration. The researchers then used a small molecule inhibitor to reduce the expression of MIR3940 and found that it inhibited the migration of cancer cells.

The team also conducted functional assays to determine if the inhibitor was effective in blocking the migration of cancer cells. They found that the inhibitor was effective in inhibiting the migration of breast cancer cells, which is a type of cancer that is highly aggressive. The researchers also found that the inhibitor was effective in reducing the number of cancer cells that had established new colonies.

MIR3940 has also been identified as a potential biomarker for cancer. The researchers found that MIR3940 was highly expressed in various tissues, including the breast tissue, and that it was associated with the development and progression of breast cancer. They also found that the expression of MIR3940 was associated with the poor prognosis of breast cancer patients.

The identification of MIR3940 as a potential drug target and biomarker has important implications for the development of new cancer therapies. The researchers are currently working on developing small molecule inhibitors of MIR3940 as a potential cancer therapy. They are also exploring the potential use of MIR3940 as a biomarker for cancer diagnosis and treatment.

In conclusion, MIR3940 is a promising drug target and biomarker for cancer. Its identification and characterization as a potential drug target and biomarker has important implications for the development of new cancer therapies. Further research is needed to fully understand the role of MIR3940 in cancer biology and to develop effective small molecule inhibitors of MIR3940 as a potential cancer therapy.

Protein Name: MicroRNA 3940

More Common Targets

MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321